Cargando…
In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair
The clinical use of human bone marrow–derived mesenchymal stem cells (BM-MSCs) has been hampered by their poor performance after transplantation into failing hearts. Here, to improve the therapeutic potential of BM-MSCs, we developed a strategy termed in vivo priming in which BM-MSCs are primed in v...
Autores principales: | Park, Bong-Woo, Jung, Soo-Hyun, Das, Sanskrita, Lee, Soon Min, Park, Jae-Hyun, Kim, Hyeok, Hwang, Ji-Won, Lee, Sunghun, Kim, Hyo-Jin, Kim, Hey-Yon, Jung, Seungman, Cho, Dong-Woo, Jang, Jinah, Ban, Kiwon, Park, Hun-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141892/ https://www.ncbi.nlm.nih.gov/pubmed/32284967 http://dx.doi.org/10.1126/sciadv.aay6994 |
Ejemplares similares
-
Enhancement strategy for effective vascular regeneration following myocardial infarction through a dual stem cell approach
por: Kim, Hyeok, et al.
Publicado: (2022) -
Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction
por: Park, Soon-Jung, et al.
Publicado: (2019) -
In Situ Preconditioning of Human Mesenchymal Stem Cells Elicits Comprehensive Cardiac Repair Following Myocardial Infarction
por: Sim, Woo-Sup, et al.
Publicado: (2021) -
Vascular regeneration and skeletal muscle repair induced by long-term exposure to SDF-1α derived from engineered mesenchymal stem cells after hindlimb ischemia
por: Kim, Jin-Ju, et al.
Publicado: (2023) -
Nanovesicles derived from iron oxide nanoparticles–incorporated mesenchymal stem cells for cardiac repair
por: Lee, Ju-Ro, et al.
Publicado: (2020)